Alternatives to Cortisone Injections in Boston, MA

cortisone injection alternatives for a city of 500k–1M — without a fake storefront

Two files matter before you open a box of cortisone injection alternatives in Boston: (1) CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. (2) Massachusetts Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, ME, NH, NY, RI, VT. We help with the second file. We do not pretend to be a Boston storefront.

What breaks first: photos, lots, or the LCD

• Adult arthritis here is 17.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Massachusetts.
• PRP is autologous and not an HCT/P 361 allograft, but payers in JK still expect diagnosis-driven documentation. A 1-minute spin does not replace a medically necessary indication or a procedure note.
• JK (National Government Services (NGS)) is the contractor that will review CTP units, application frequency, and wound measurements for Massachusetts Part B claims. Practices that skip MAC education typically see denials before they see outcomes.

Massachusetts Department of Public Health vs. the IFU

6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 675,647 residents will still mix those payers. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

A practical checklist for Boston